Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

72.58
BATS BZX Real-Time Price
As of 3:18pm ET
 -0.16 / -0.22%
Today’s Change
55.06
Today|||52-Week Range
73.67
+15.91%
Year-to-Date
Bristol-Myers Reports Data on Immuno-Oncology Drug Empliciti
10:39am / Zacks.com - Paid Partner Content
Samsung Could Sell More Drugs
Jun 23 / TheStreet.com - Paid Partner Content
Gilead's (GILD) HCV Drug Application Accepted in the EU
10:39am / Zacks.com - Paid Partner Content
Dems Roast Trump for Leaving Medicare Out of Drug Price Order
Jun 21 / TheStreet.com - Paid Partner Content
AbbVie's HCV Combo Drug Gets Positive CHMP Opinion in EU
10:30am / Zacks.com - Paid Partner Content
J&J-AbbVie's Imbruvica Positive in Follow-up Lymphoma Study
Jun 20 / Zacks.com - Paid Partner Content
Sanofi/Regeneron's Kevzara Gets Marketing Approval in EU
10:18am / Zacks.com - Paid Partner Content
Global pharma sales forecasts cut amid pricing pressures
Jun 20 / FT.com - Paid Partner Content
What Apple, Microsoft and Some of the World's Biggest Tech Companies Are Doing Now in...
Jun 24 / TheStreet.com - Paid Partner Content
AbbVie (ABBV) Stock Hits 52-Week High: More Room to Run?
Jun 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close72.74
Today’s open72.77
Day’s range72.26 - 73.05
Volume228,128
Average volume (3 months)6,001,208
Market cap$115.8B
Dividend yield3.53%
Data as of 3:18pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.75%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)+12.16%
P/E ratio18.8
Price/Sales3.98
Price/Book24.99

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.05-0.11%
CELGCelgene-1.68-1.26%
SNYSanofi-0.12-0.24%
BMYBristol-Myers Squibb-0.84-1.48%
Data as of 3:19pm ET, 06/27/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$1.40
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts